Insider plans sale of 42,064 common shares

A holder associated with CRBD has filed a Rule 144 notice to sell up to 42,064 common shares through UBS Financial Services on the NYSE, with an approximate sale date of February 17, 2026.

Rhea-AI Filing Summary

A holder associated with CRBD has filed a Rule 144 notice to sell up to 42,064 common shares through UBS Financial Services on the NYSE, with an approximate sale date of February 17, 2026. The filing lists an aggregate market value of $1,322,492.16 for these shares, compared with 481,685,891 common shares outstanding as a baseline figure. The securities to be sold were acquired from the issuer via restricted stock units on January 30, 2023 (34,236 shares) and via stock option exercise on February 17, 2026 (7,828 shares, paid in cash). The signer represents that they are not aware of undisclosed material adverse information about the issuer’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CRBD Form 144 filing disclose?

The Form 144 filing discloses a planned sale of up to 42,064 common shares of CRBD under Rule 144, with an aggregate market value of $1,322,492.16, to be executed through UBS Financial Services on the NYSE around February 17, 2026.

How many CRBD shares are planned for sale and what is their value?

The notice covers a proposed sale of 42,064 CRBD common shares with an aggregate market value of $1,322,492.16. This contrasts with 481,685,891 common shares outstanding for the issuer, indicating the planned sale is small relative to the total share base.

How were the CRBD shares in this Form 144 acquired?

The shares were acquired directly from the issuer via restricted stock units and stock options. 34,236 shares came from RSUs granted and settled on January 30, 2023, and 7,828 shares were obtained by exercising stock options for cash on February 17, 2026.

Who is the broker for the planned CRBD Rule 144 sale?

The planned sale of 42,064 CRBD common shares will be handled by UBS Financial Services, Inc., listed at Eleven Madison Avenue, 4th Floor, New York, NY 10010. The filing also notes that the shares are listed on the NYSE.

What representation does the CRBD insider make in the Form 144?

The person for whose account the CRBD securities will be sold represents that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations, consistent with Rule 144 requirements for affiliate sales and, if applicable, Rule 10b5-1 trading plans.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:12 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001923231
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corebridge Financial, Inc.
SEC File Number	001-41504
Address of Issuer	2919 ALLEN PARKWAY WOODSON TOWER HOUSTON TEXAS 77019
Phone	1-877-375-2422
Name of Person for Whose Account the Securities are To Be Sold	Ditillo David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	CIO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. Eleven Madison Avenue 4th Floor New York NY 10010	42064	1322492.16	481685891	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2023	RSU	Issuer			34236	01/30/2023	NA
Common	02/17/2026	Exercise of stock options	Issuer			7828	02/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for David Ditillo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)